REFERENCE
Pfizer.Pfizer Suspends Tanezumab Osteoarthritis Clinical Trial Program. Media Release: 23 Jun 2010. Available from: URL: http://www.pfizer.com
Rights and permissions
About this article
Cite this article
At the request of the US FDA, Pfizer has suspended its osteoarthritis (OA) clinical programme for tanezumab.. React. Wkly. 1308, 3 (2010). https://doi.org/10.2165/00128415-201013080-00007
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128415-201013080-00007